子宫肿块MRI评估平滑肌肉瘤风险的共识声明
该共识声明基于证据综述,针对拟诊子宫肌瘤的女性,提出MRI评估子宫肿块以区分平滑肌肉瘤风险的术语与影像定义,旨在术前识别高风险患者以规划肿瘤学手术,同时为低风险患者保留生育力保留的腹腔镜肌瘤剔除术。声明还确定了未来研究的最高优先事项。
要点
- 术前MRI评估可用于识别平滑肌肉瘤高风险子宫肿块,指导手术方式选择。
- 共识统一了影像与疾病相关术语,以提高解读的一致性和可靠性。
- 腹腔镜肌瘤剔除术中非封闭式电动粉碎可导致恶性肿瘤播散,需避免。
局限性
- 原文未详细报告共识制定的具体方法学细节(如证据分级、专家构成等)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Laparoscopic myomectomy, a common gynecologic operation in premenopausal women, has become heavily regulated since 2014 following the dissemination of unsuspected uterine leiomyosarcoma (LMS) throughout the pelvis of a physician treated for symptomatic leiomyoma. Research since that time suggests a higher prevalence than previously suspected of uterine LMS in resected masses presumed to represent leiomyoma, as high as one in 770 women (0.13%). Though rare, the dissemination of an aggressive malignant neoplasm due to noncontained electromechanical morcellation in laparoscopic myomectomy is a devastating outcome. Gynecologic surgeons' desire for an evidence-based, noninvasive evaluation for LMS is driven by a clear need to avoid such harms while maintaining the availability of minimally invasive surgery for symptomatic leiomyoma. Laparoscopic gynecologists could rely upon the distinction of higher-risk uterine masses preoperatively to plan oncologic surgery (ie, potential hysterectomy) for patients with elevated risk for LMS and, conversely, to safely offer women with no or minimal indicators of elevated risk the fertility-preserving laparoscopic myomectomy. MRI evaluation for LMS may potentially serve this purpose in symptomatic women with leiomyomas. This evidence review and consensus statement defines imaging and disease-related terms to allow more uniform and reliable interpretation and identifies the highest priorities for future research on LMS evaluation.
引用
- Hindman, Kang, Fournier, et al. MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement. Radiology. 2022. PMID: 36194109. doi:10.1148/radiol.211658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。